TY  - GEN
AU  - Nakamura,Mashio
AU  - Nishikawa,Masakatsu
AU  - Komuro,Issei
AU  - Kitajima,Isao
AU  - Uetsuka,Yoshio
AU  - Yamagami,Takuji
AU  - Minamiguchi,Hiroki
AU  - Yoshimatsu,Rika
AU  - Tanabe,Kosuke
AU  - Matsuoka,Nobushige
AU  - Kanmuri,Kazuhiro
AU  - Ogawa,Hisao
TI  - Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study)
SN  - 1347-4820
PY  - 2016///0301
KW  - Aged
KW  - Aged, 80 and over
KW  - Anticoagulants
KW  - adverse effects
KW  - Factor Xa Inhibitors
KW  - Female
KW  - Hemorrhage
KW  - chemically induced
KW  - Heparin
KW  - Humans
KW  - International Normalized Ratio
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Pulmonary Embolism
KW  - drug therapy
KW  - Pyrazoles
KW  - Pyridones
KW  - Recurrence
KW  - Treatment Outcome
KW  - Venous Thromboembolism
KW  - Venous Thrombosis
KW  - Warfarin
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1253/circj.CJ-15-0195
ER  -